Ocular Implants Market- Industry Analysis and Forecast (2022-2029)


Ocular Implants Market was valued US$ 13.27  Bn in 2021 and is expected to reach US$ 22.16 Bn by 2029, at a CAGR of 6.62 % during a forecast period.

Ocular Implants Market Drivers and Restraints

An increase in the occurrence of cataracts is one of the key drivers in the global ocular implants market growth. The Cataract has identified as a leading cause of blindness, which has encouraged many industry key players and government organizations to develop innovative ocular implants. In addition, technological advancements, adoption of vision correction procedures, and intraocular lenses for cataract surgeries are some of the driving factors, which are expected to propel the growth in the market. For instance, an introduction of a new collagen glaucoma implant, which inhibits the formation of scar is expected to contribute significant share in the global ocular implants market. On the other hand, lack of skilled professionals and the side effects are expected to limit the growth in the market.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.Ocular Implants MarketTo know about the Research Methodology :- Request Free Sample Report

Ocular Implants Market Segmentation Analysis

In terms of product, Ocular Implants are segmented by corneal implants, intraocular lenses, glaucoma implants, orbital implants, ocular prosthesis, and others. Glaucoma implants are expected to contribute a significant share of xx% during the forecast period (2022-2029). Intraocular lenses have gained popularity among the consumers because of their comprehensive use in presbyopia, nearsightedness, and farsightedness. Glaucoma is one of the primary reasons for blindness.

On the basis of the application, market is segmented into oculoplastic, glaucoma surgery, and AMD, drug delivery, and age-related macular degeneration, aesthetics, and others. Glaucoma surgery segment held the largest share in 2021 because of the rise in the incidence of glaucoma. Increasing awareness about glaucoma disease is increasing demand for early glaucoma surgical treatment.

By the end-use, the ocular implants market is segmented into ophthalmic clinics, hospitals, and specialty eye institutes. Among these, hospital segment is expected to hold the largest share in the market because of rise in frequency of treatment for vision impairment. Furthermore, the specialty eye institutes are projected to be the fastest-growing segment in the market during the forecast period (2022-2029). Eye research institutes play a vital role in the technological innovations of intraocular lenses. An introduction of various advanced intraocular lenses and an increase in competition amongst key players for the development of superior lenses and high investment on eye research institutes by government and nongovernment organizations are expected to drive the market growth.

Ocular Implants Market Regional Analysis

North America held the dominant position in the global ocular implants market and is expected to continue its dominant position during the forecast period. An increase in the geriatric population and the presence of reimbursement facilities are transforming the healthcare industry in the region. As per the country analysis, the rise in government expenditure for R&D is one of the key drivers, which is expected to contribute significant share in the market. For instance, the U.S. government has offered nearly about 44% of its allocated fund to the eye research institutes for R&D. Furthermore, the Asia Pacific region is projected to grow at a xx% rate of CAGR during the forecast period. Eye-related disorders have occurred as potential threats to the populations in all middle-income across the region.The high growth rate of diabetic patients and the government healthcare expenditures in Asian countries are boosting the market growth.

The objective of the report is to present a comprehensive analysis of the Global Ocular Implants Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Ocular Implants Market dynamics, structure by analyzing the market segments and project the Global Ocular Implants Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Ocular Implants Market make the report investor’s guide.

Ocular Implants Market Scope: Inquire before buying






Global Ocular Implants Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 13.27 Bn.




Forecast Period 2022 to 2029 CAGR:
6.62%
Market Size in 2029:
US $ 22.16 Bn.




 Segments Covered:
by Product
• Intraocular lenses
• Glaucoma implants
• Corneal implants
• Ocular prosthesis
• Orbital implants
• Others




by Application
• Age-related macular degeneration
• Oculoplasty
• Drug delivery
• Glaucoma surgery
• Aesthetic purpose




by End-use
• Clinics
• Specialty eye institutes
• Hospitals






Ocular Implants Market, by Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Ocular Implants Market Key Players are:

• Bausch & Lomb
• Alcon
• Carl Zeiss
• Johnson & Johnson
• MORCHER GmbH
• STAAR surgical
• Porex Corporation
• FCI Ophthalmics
• Gulden Ophthalmics
• MOLTENO OPHTHALMIC Ltd
• Bio-Eye Orbital Implants
• ZEISS International
• Hoya Corporation
• Glaukos
• Second Sight
• Allergan
• Novartis AG
• Pfizer Inc.
• PhysIOL

Frequently Asked Questions:

1. Which region has the largest share in Global Ocular Implants Market?
Ans: North America region held the highest share in 2021.

2. What is the growth rate of Global Ocular Implants Market?
Ans: The Global Ocular Implants Market is growing at a CAGR of 6.62% during forecasting period 2022-2029.

3. What is scope of the Global Ocular Implants market report?
Ans: Global Ocular Implants Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Ocular Implants market?
Ans: The important key players in the Global Ocular Implants Market are – Bausch & Lomb, Alcon, Carl Zeiss, Johnson & Johnson, MORCHER GmbH, STAAR surgical, Porex Corporation, FCI Ophthalmics, Gulden Ophthalmics, MOLTENO OPHTHALMIC Ltd, Bio-Eye Orbital Implants, ZEISS International, Hoya Corporation, Glaukos, Second Sight, Allergan, Novartis AG, Pfizer Inc., and PhysIOL

5. What is the study period of this market?
Ans: The Global Ocular Implants Market is studied from 2021 to 2029. 




Global ocular implants market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Ocular Implants Market Size, by Market Value (US$ Mn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators
6. Global Ocular Implants Market Analysis and Forecast
6.1. Ocular Implants Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Ocular Implants Market Analysis and Forecast, by product
7.1. Introduction and Definition
7.2. Key Findings
7.3. Ocular Implants Market Value Share Analysis, by product
7.4. Ocular Implants Market Size (US$ Mn) Forecast, by product
7.5. Ocular Implants Market Analysis, by product
7.6. Ocular Implants Market Attractiveness Analysis, by product

8. Global Ocular Implants Market Analysis and Forecast, By Application
8.1. Introduction and Definition
8.2. Key Findings
8.3. Ocular Implants Market Value Share Analysis, By Application
8.4. Ocular Implants Market Size (US$ Mn) Forecast, By Application
8.5. Ocular Implants Market Analysis, By Application
8.6. Ocular Implants Market Attractiveness Analysis, By Application

9. Global Ocular Implants Market Analysis and Forecast, By End-use
9.1. Introduction and Definition
9.2. Key Findings
9.3. Ocular Implants Market Value Share Analysis, By End-use
9.4. Ocular Implants Market Size (US$ Mn) Forecast, By End-use
9.5. Ocular Implants Market Analysis, By End-use
9.6. Ocular Implants Market Attractiveness Analysis, By End-use

10. Global Ocular Implants Market Analysis, by Region
10.1. Ocular Implants Market Value Share Analysis, by Region
10.2. Ocular Implants Market Size (US$ Mn) Forecast, by Region
10.3. Ocular Implants Market Attractiveness Analysis, by Region

11. North America Ocular Implants Market Analysis
11.1. Key Findings
11.2. North America Ocular Implants Market Overview
11.3. North America Ocular Implants Market Value Share Analysis, by product
11.4. North America Ocular Implants Market Forecast, by product
11.4.1. Intraocular lenses
11.4.2. Glaucoma implants
11.4.3. Corneal implants
11.4.4. Ocular prosthesis
11.4.5. Orbital implants
11.4.6. Others
11.5. North America Ocular Implants Market Value Share Analysis, By Application
11.6. North America Ocular Implants Market Forecast, By Application
11.6.1. Age-related macular degeneration
11.6.2. Oculoplasty
11.6.3. Drug delivery
11.6.4. Glaucoma surgery
11.6.5. Aesthetic purpose
11.7. North America Ocular Implants Market Value Share Analysis, By End-use
11.8. North America Ocular Implants Market Forecast, By End-use
11.8.1. Clinics
11.8.2. Specialty eye institutes
11.8.3. Hospitals
11.9. North America Ocular Implants Market Value Share Analysis, by Country
11.10. North America Ocular Implants Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Ocular Implants Market Analysis, by Country
11.12. U.S. Ocular Implants Market Forecast, by product
11.12.1. Intraocular lenses
11.12.2. Glaucoma implants
11.12.3. Corneal implants
11.12.4. Ocular prosthesis
11.12.5. Orbital implants
11.12.6. Others
11.13. U.S. Ocular Implants Market Forecast, By Application
11.13.1. Age-related macular degeneration
11.13.2. Oculoplasty
11.13.3. Drug delivery
11.13.4. Glaucoma surgery
11.13.5. Aesthetic purpose
11.14. U.S. Ocular Implants Market Forecast, By End-use
11.14.1. Clinics
11.14.2. Specialty eye institutes
11.14.3. Hospitals
11.15. Canada Ocular Implants Market Forecast, by product
11.15.1. Intraocular lenses
11.15.2. Glaucoma implants
11.15.3. Corneal implants
11.15.4. Ocular prosthesis
11.15.5. Orbital implants
11.15.6. Others
11.16. Canada Ocular Implants Market Forecast, By Application
11.16.1. Age-related macular degeneration
11.16.2. Oculoplasty
11.16.3. Drug delivery
11.16.4. Glaucoma surgery
11.16.5. Aesthetic purpose
11.17. Canada Ocular Implants Market Forecast, By End-use
11.17.1. Clinics
11.17.2. Specialty eye institutes
11.17.3. Hospitals
11.18. North America Ocular Implants Market Attractiveness Analysis
11.18.1. By product
11.18.2. By Application
11.18.3. By End-use
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments

12. Europe Ocular Implants Market Analysis
12.1. Key Findings
12.2. Europe Ocular Implants Market Overview
12.3. Europe Ocular Implants Market Value Share Analysis, by product
12.4. Europe Ocular Implants Market Forecast, by product
12.4.1. Intraocular lenses
12.4.2. Glaucoma implants
12.4.3. Corneal implants
12.4.4. Ocular prosthesis
12.4.5. Orbital implants
12.4.6. Others
12.5. Europe Ocular Implants Market Value Share Analysis, By Application
12.6. Europe Ocular Implants Market Forecast, By Application
12.6.1. Age-related macular degeneration
12.6.2. Oculoplasty
12.6.3. Drug delivery
12.6.4. Glaucoma surgery
12.6.5. Aesthetic purpose
12.7. Europe Ocular Implants Market Value Share Analysis, By End-use
12.8. Europe Ocular Implants Market Forecast, By End-use
12.8.1. Clinics
12.8.2. Specialty eye institutes
12.8.3. Hospitals
12.9. Europe Ocular Implants Market Value Share Analysis, by Country
12.10. Europe Ocular Implants Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Ocular Implants Market Analysis, by Country
12.12. Germany Ocular Implants Market Forecast, by product
12.12.1. Intraocular lenses
12.12.2. Glaucoma implants
12.12.3. Corneal implants
12.12.4. Ocular prosthesis
12.12.5. Orbital implants
12.12.6. Others
12.13. Germany Ocular Implants Market Forecast, By Application
12.13.1. Age-related macular degeneration
12.13.2. Oculoplasty
12.13.3. Drug delivery
12.13.4. Glaucoma surgery
12.13.5. Aesthetic purpose
12.14. Germany Ocular Implants Market Forecast, By End-use
12.14.1. Clinics
12.14.2. Specialty eye institutes
12.14.3. Hospitals
12.15. U.K. Ocular Implants Market Forecast, by product
12.15.1. Intraocular lenses
12.15.2. Glaucoma implants
12.15.3. Corneal implants
12.15.4. Ocular prosthesis
12.15.5. Orbital implants
12.15.6. Others
12.16. U.K. Ocular Implants Market Forecast, By Application
12.16.1. Age-related macular degeneration
12.16.2. Oculoplasty
12.16.3. Drug delivery
12.16.4. Glaucoma surgery
12.16.5. Aesthetic purpose
12.17. U.K. Ocular Implants Market Forecast, By End-use
12.17.1. Clinics
12.17.2. Specialty eye institutes
12.17.3. Hospitals
12.18. France Ocular Implants Market Forecast, by product
12.18.1. Intraocular lenses
12.18.2. Glaucoma implants
12.18.3. Corneal implants
12.18.4. Ocular prosthesis
12.18.5. Orbital implants
12.18.6. Others
12.19. France Ocular Implants Market Forecast, By Application
12.19.1. Age-related macular degeneration
12.19.2. Oculoplasty
12.19.3. Drug delivery
12.19.4. Glaucoma surgery
12.19.5. Aesthetic purpose
12.20. France Ocular Implants Market Forecast, By End-use
12.20.1. Clinics
12.20.2. Specialty eye institutes
12.20.3. Hospitals
12.21. Italy Ocular Implants Market Forecast, by product
12.21.1. Intraocular lenses
12.21.2. Glaucoma implants
12.21.3. Corneal implants
12.21.4. Ocular prosthesis
12.21.5. Orbital implants
12.21.6. Others
12.22. Italy Ocular Implants Market Forecast, By Application
12.22.1. Age-related macular degeneration
12.22.2. Oculoplasty
12.22.3. Drug delivery
12.22.4. Glaucoma surgery
12.22.5. Aesthetic purpose
12.23. Italy Ocular Implants Market Forecast, By End-use
12.23.1. Clinics
12.23.2. Specialty eye institutes
12.23.3. Hospitals
12.24. Spain Ocular Implants Market Forecast, by product
12.24.1. Intraocular lenses
12.24.2. Glaucoma implants
12.24.3. Corneal implants
12.24.4. Ocular prosthesis
12.24.5. Orbital implants
12.24.6. Others
12.25. Spain Ocular Implants Market Forecast, By Application
12.25.1. Age-related macular degeneration
12.25.2. Oculoplasty
12.25.3. Drug delivery
12.25.4. Glaucoma surgery
12.25.5. Aesthetic purpose
12.26. Spain Ocular Implants Market Forecast, By End-use
12.26.1. Clinics
12.26.2. Specialty eye institutes
12.26.3. Hospitals
12.27. Rest of Europe Ocular Implants Market Forecast, by product
12.27.1. Intraocular lenses
12.27.2. Glaucoma implants
12.27.3. Corneal implants
12.27.4. Ocular prosthesis
12.27.5. Orbital implants
12.27.6. Others
12.28. Rest of Europe Ocular Implants Market Forecast, By Application
12.28.1. Age-related macular degeneration
12.28.2. Oculoplasty
12.28.3. Drug delivery
12.28.4. Glaucoma surgery
12.28.5. Aesthetic purpose
12.29. Rest Of Europe Ocular Implants Market Forecast, By End-use
12.29.1. Clinics
12.29.2. Specialty eye institutes
12.29.3. Hospitals
12.30. Europe Ocular Implants Market Attractiveness Analysis
12.30.1. By product
12.30.2. By Application
12.30.3. By End-use
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments

13. Asia Pacific Ocular Implants Market Analysis
13.1. Key Findings
13.2. Asia Pacific Ocular Implants Market Overview
13.3. Asia Pacific Ocular Implants Market Value Share Analysis, by product
13.4. Asia Pacific Ocular Implants Market Forecast, by product
13.4.1. Intraocular lenses
13.4.2. Glaucoma implants
13.4.3. Corneal implants
13.4.4. Ocular prosthesis
13.4.5. Orbital implants
13.4.6. Others
13.5. Asia Pacific Ocular Implants Market Value Share Analysis, By Application
13.6. Asia Pacific Ocular Implants Market Forecast, By Application
13.6.1. Age-related macular degeneration
13.6.2. Oculoplasty
13.6.3. Drug delivery
13.6.4. Glaucoma surgery
13.6.5. Aesthetic purpose
13.7. Asia Pacific Ocular Implants Market Value Share Analysis, By End-use
13.8. Asia Pacific Ocular Implants Market Forecast, By End-use
13.8.1. Clinics
13.8.2. Specialty eye institutes
13.8.3. Hospitals
13.9. Asia Pacific Ocular Implants Market Value Share Analysis, by Country
13.10. Asia Pacific Ocular Implants Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Ocular Implants Market Analysis, by Country
13.12. China Ocular Implants Market Forecast, by product
13.12.1. Intraocular lenses
13.12.2. Glaucoma implants
13.12.3. Corneal implants
13.12.4. Ocular prosthesis
13.12.5. Orbital implants
13.12.6. Others
13.13. China Ocular Implants Market Forecast, By Application
13.13.1. Age-related macular degeneration
13.13.2. Oculoplasty
13.13.3. Drug delivery
13.13.4. Glaucoma surgery
13.13.5. Aesthetic purpose
13.14. China Ocular Implants Market Forecast, By End-use
13.14.1. Clinics
13.14.2. Specialty eye institutes
13.14.3. Hospitals
13.15. India Ocular Implants Market Forecast, by product
13.15.1. Intraocular lenses
13.15.2. Glaucoma implants
13.15.3. Corneal implants
13.15.4. Ocular prosthesis
13.15.5. Orbital implants
13.15.6. Others
13.16. India Ocular Implants Market Forecast, By Application
13.16.1. Age-related macular degeneration
13.16.2. Oculoplasty
13.16.3. Drug delivery
13.16.4. Glaucoma surgery
13.16.5. Aesthetic purpose
13.17. India Ocular Implants Market Forecast, By End-use
13.17.1. Clinics
13.17.2. Specialty eye institutes
13.17.3. Hospitals
13.18. Japan Ocular Implants Market Forecast, by product
13.18.1. Intraocular lenses
13.18.2. Glaucoma implants
13.18.3. Corneal implants
13.18.4. Ocular prosthesis
13.18.5. Orbital implants
13.18.6. Others
13.19. Japan Ocular Implants Market Forecast, By Application
13.19.1. Age-related macular degeneration
13.19.2. Oculoplasty
13.19.3. Drug delivery
13.19.4. Glaucoma surgery
13.19.5. Aesthetic purpose
13.20. Japan Ocular Implants Market Forecast, By End-use
13.20.1. Clinics
13.20.2. Specialty eye institutes
13.20.3. Hospitals
13.21. ASEAN Ocular Implants Market Forecast, by product
13.21.1. Intraocular lenses
13.21.2. Glaucoma implants
13.21.3. Corneal implants
13.21.4. Ocular prosthesis
13.21.5. Orbital implants
13.21.6. Others
13.22. ASEAN Ocular Implants Market Forecast, By Application
13.22.1. Age-related macular degeneration
13.22.2. Oculoplasty
13.22.3. Drug delivery
13.22.4. Glaucoma surgery
13.22.5. Aesthetic purpose
13.23. ASEAN Ocular Implants Market Forecast, By End-use
13.23.1. Clinics
13.23.2. Specialty eye institutes
13.23.3. Hospitals
13.24. Rest of Asia Pacific Ocular Implants Market Forecast, by product
13.24.1. Intraocular lenses
13.24.2. Glaucoma implants
13.24.3. Corneal implants
13.24.4. Ocular prosthesis
13.24.5. Orbital implants
13.24.6. Others
13.25. Rest of Asia Pacific Ocular Implants Market Forecast, By Application
13.25.1. Age-related macular degeneration
13.25.2. Oculoplasty
13.25.3. Drug delivery
13.25.4. Glaucoma surgery
13.25.5. Aesthetic purpose
13.26. Rest of Asia Pacific Ocular Implants Market Forecast, By End-use
13.26.1. Clinics
13.26.2. Specialty eye institutes
13.26.3. Hospitals
13.27. Asia Pacific Ocular Implants Market Attractiveness Analysis
13.27.1. By product
13.27.2. By Application
13.27.3. By End-use
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments

14. Middle East & Africa Ocular Implants Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Ocular Implants Market Overview
14.3. Middle East & Africa Ocular Implants Market Value Share Analysis, by product
14.4. Middle East & Africa Ocular Implants Market Forecast, by product
14.4.1. Intraocular lenses
14.4.2. Glaucoma implants
14.4.3. Corneal implants
14.4.4. Ocular prosthesis
14.4.5. Orbital implants
14.4.6. Others
14.5. Middle East & Africa Ocular Implants Market Value Share Analysis, By Application
14.6. Middle East & Africa Ocular Implants Market Forecast, By Application
14.6.1. Age-related macular degeneration
14.6.2. Oculoplasty
14.6.3. Drug delivery
14.6.4. Glaucoma surgery
14.6.5. Aesthetic purpose
14.7. Middle East & Africa Ocular Implants Market Value Share Analysis, By End-use
14.8. Middle East & Africa Ocular Implants Market Forecast, By End-use
14.8.1. Clinics
14.8.2. Specialty eye institutes
14.8.3. Hospitals
14.9. Middle East & Africa Ocular Implants Market Value Share Analysis, by Country
14.10. Middle East & Africa Ocular Implants Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Ocular Implants Market Analysis, by Country
14.12. GCC Ocular Implants Market Forecast, by product
14.12.1. Intraocular lenses
14.12.2. Glaucoma implants
14.12.3. Corneal implants
14.12.4. Ocular prosthesis
14.12.5. Orbital implants
14.12.6. Others
14.13. GCC Ocular Implants Market Forecast, By Application
14.13.1. Age-related macular degeneration
14.13.2. Oculoplasty
14.13.3. Drug delivery
14.13.4. Glaucoma surgery
14.13.5. Aesthetic purpose
14.14. GCC Ocular Implants Market Forecast, By End-use
14.14.1. Clinics
14.14.2. Specialty eye institutes
14.14.3. Hospitals
14.15. South Africa Ocular Implants Market Forecast, by product
14.15.1.1. Intraocular lenses
14.15.1.2. Glaucoma implants
14.15.1.3. Corneal implants
14.15.1.4. Ocular prosthesis
14.15.1.5. Orbital implants
14.15.1.6. Others
14.16. South Africa Ocular Implants Market Forecast, By Application
14.16.1.1. Age-related macular degeneration
14.16.1.2. Oculoplasty
14.16.1.3. Drug delivery
14.16.1.4. Glaucoma surgery
14.16.1.5. Aesthetic purpose
14.17. South Africa Ocular Implants Market Forecast, By End-use
14.17.1. Clinics
14.17.2. Specialty eye institutes
14.17.3. Hospitals
14.18. Rest of Middle East & Africa Ocular Implants Market Forecast, by product
14.18.1.1. Intraocular lenses
14.18.1.2. Glaucoma implants
14.18.1.3. Corneal implants
14.18.1.4. Ocular prosthesis
14.18.1.5. Orbital implants
14.18.1.6. Others
14.19. Rest of Middle East & Africa Ocular Implants Market Forecast, By Application
14.19.1.1. Age-related macular degeneration
14.19.1.2. Oculoplasty
14.19.1.3. Drug delivery
14.19.1.4. Glaucoma surgery
14.19.1.5. Aesthetic purpose
14.20. & Africa Ocular Implants Market Forecast, By End-use
14.20.1. Clinics
14.20.2. Specialty eye institutes
14.20.3. Hospitals
14.21. Middle East & Africa Ocular Implants Market Attractiveness Analysis
14.21.1. By product
14.21.2. By Application
14.21.3. By End-use
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments

15. South America Ocular Implants Market Analysis
15.1. Key Findings
15.2. South America Ocular Implants Market Overview
15.3. South America Ocular Implants Market Value Share Analysis, by product
15.4. South America Ocular Implants Market Forecast, by product
15.4.1. Intraocular lenses
15.4.2. Glaucoma implants
15.4.3. Corneal implants
15.4.4. Ocular prosthesis
15.4.5. Orbital implants
15.4.6. Others
15.5. South America Ocular Implants Market Value Share Analysis, By Application
15.6. South America Ocular Implants Market Forecast, By Application
15.6.1. Age-related macular degeneration
15.6.2. Oculoplasty
15.6.3. Drug delivery
15.6.4. Glaucoma surgery
15.6.5. Aesthetic purpose
15.7. South America Ocular Implants Market Value Share Analysis, By End-use
15.8. South America Ocular Implants Market Forecast, By End-use
15.8.1. Clinics
15.8.2. Specialty eye institutes
15.8.3. Hospitals
15.9. South America Ocular Implants Market Value Share Analysis, by Country
15.10. South America Ocular Implants Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Ocular Implants Market Analysis, by Country
15.12. Brazil Ocular Implants Market Forecast, by product
15.12.1. Intraocular lenses
15.12.2. Glaucoma implants
15.12.3. Corneal implants
15.12.4. Ocular prosthesis
15.12.5. Orbital implants
15.12.6. Others
15.13. Brazil Ocular Implants Market Forecast, By Application
15.13.1. Age-related macular degeneration
15.13.2. Oculoplasty
15.13.3. Drug delivery
15.13.4. Glaucoma surgery
15.13.5. Aesthetic purpose
15.14. Brazil Ocular Implants Market Forecast, By End-use
15.14.1. Clinics
15.14.2. Specialty eye institutes
15.14.3. Hospitals
15.15. Mexico Ocular Implants Market Forecast, by product
15.15.1. Intraocular lenses
15.15.2. Glaucoma implants
15.15.3. Corneal implants
15.15.4. Ocular prosthesis
15.15.5. Orbital implants
15.15.6. Others
15.16. Mexico Ocular Implants Market Forecast, By Application
15.16.1. Age-related macular degeneration
15.16.2. Oculoplasty
15.16.3. Drug delivery
15.16.4. Glaucoma surgery
15.16.5. Aesthetic purpose
15.17. Mexico Ocular Implants Market Forecast, By End-use
15.17.1. Clinics
15.17.2. Specialty eye institutes
15.17.3. Hospitals
15.18. Rest of South America Ocular Implants Market Forecast, by product
15.18.1. Intraocular lenses
15.18.2. Glaucoma implants
15.18.3. Corneal implants
15.18.4. Ocular prosthesis
15.18.5. Orbital implants
15.18.6. Others
15.19. Rest of South America Ocular Implants Market Forecast, By Application
15.19.1. Age-related macular degeneration
15.19.2. Oculoplasty
15.19.3. Drug delivery
15.19.4. Glaucoma surgery
15.19.5. Aesthetic purpose
15.20. Rest of South America Ocular Implants Market Forecast, By End-use
15.20.1. Clinics
15.20.2. Specialty eye institutes
15.20.3. Hospitals
15.21. South America Ocular Implants Market Attractiveness Analysis
15.21.1. By product
15.21.2. By Application
15.21.3. By End-use
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward
16.2.3.3. Integration
16.3. Company Profiles: Key Players
16.3.1. Bausch & Lomb
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. Alcon
16.3.3. Carl Zeiss
16.3.4. Johnson & Johnson
16.3.5. MORCHER GmbH
16.3.6. STAAR surgical
16.3.7. Porex Corporation
16.3.8. FCI Ophthalmics
16.3.9. Gulden Ophthalmics
16.3.10. MOLTENO OPHTHALMIC Ltd
16.3.11. Bio-Eye Orbital Implants
16.3.12. ZEISS International
16.3.13. Hoya Corporation
16.3.14. Glaukos
16.3.15. Second Sight
16.3.16. Allergan
16.3.17. Novartis AG
16.3.18. Pfizer Inc.
16.3.19. PhysIOL

17. Primary Key Insights
  • INQUIRE BEFORE BUYING